Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2025-12-26 @ 1:19 PM
NCT ID:
NCT00440206
Eligibility Criteria:
Inclusion Criteria:
* Patient must be HIV infected
* must be \≥18 years old
* must have been taking the same combination ARV regimen (\≥3 drugs) for at least 3 months.
* Must be experiencing virologic failure (viral load \≥50 copies/mL on two occasions at least 2 weeks apart).
* must be changed to a salvage antiretroviral regimen
* Patient has to have signed and dated a full infomred consent.
Exclusion Criteria:
* Patient with any of the following abnormal laboratory test results in the previous 3 months:
* Hemaglobin \<100 g/L
* Platelet count \<20,000 cells/L
* INR \≥3.5 IU
* PTT \≥60 IU
* Patient with other significant underlying disease (non-HIV) that might impact immune markers ( eg. advanced liver disease, malignancy).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00440206
Study Brief:
Protocol Section:
NCT00440206